Tag: contract
-
Retina Implant, Stem Cell Studies Set for Space Station
A company providing laboratory modules for biomedical research on the International Space Station received funding from NASA for three new projects.
-
Synthetic DNA Studied for Mass Data Storage
An industry-academic consortium received a U.S. government contract to develop coded synthetic polymer chemicals like DNA for reliably storing massive amounts of data.
-
A.I., Robotics Studied for Military Trauma System
Medical and robotics labs at two universities in Pittsburgh are developing a portable, autonomous trauma care device to stabilize wounded military service people in the field.
-
Platform to Integrate Robotics, Synthetic Biology, A.I.
Two companies are developing a new model for a cloud-based platform that makes possible automated collaborative research with artificial intelligence in synthetic biology.
-
Zika Vaccine Clinical Trial Underway
The first of a series of clinical trials testing inactivated Zika particles as a vaccine to protect against the live Zika virus is recruiting participants.
-
Health Agency Funds Drug-Resistant Bacteria R&D
Biomedical Advanced Research and Development Authority, or BARDA, signed agreements worth $67 million to develop new treatments and diagnostics for urgent drug-resistant infections.
-
Influenza A Therapy Shown Working in Trial
5 October 2015. A clinical trial testing a synthetic antibody designed to treat influenza A shows the treatment is effective in reducing the spread of flu viruses in humans. Visterra Inc., the therapy’s designer, also received a contract valued as much as $204.5 million from the U.S. Department of Health and Human Services to further…
-
Regeneron to Develop Antibody Therapy for Ebola
21 September 2015. Regeneron Pharmaceuticals Inc. received a contract from the U.S. Department of Health and Human Services to develop an engineered antibody designed to treat Ebola infections. The initial $17 million contract from HHS’s Biomedical Advanced Research and Development Authority or BARDA covers initial development and testing work on the therapy, but the program…
-
Ebola-Marburg Vaccine Development, Testing Contract Awarded
31 October 2014. A biodefense unit of the U.S. Department of Defense awarded a contract to vaccine maker Profectus BioSciences Inc. for development and testing of a vaccine protecting against the two major Ebola strains and related Marburg viruses. The $9.5 million contract with the Baltimore company came from DoD’s Medical Countermeasure Systems-Joint Vaccine Acquisition…
-
Clinical Trial to Test Safety of MRSA Drug Candidate
Enanta Pharmaceuticals, a biotechnology company in Watertown, Massachusetts, is starting an early-stage clinical trial of an antibiotic to treat methicillin-resistant Staphylococcus aureus or MRSA infections. The drug, code-named EDP-788, is being developed under a contract with National Institute of Allergy and Infectious Diseases, part of National Institutes of Health. MRSA is a bacteria resistant to many…